Same-Day Discharge After Laparoscopic Hysterectomy Deemed Safe
By HospiMedica International staff writers Posted on 23 May 2011 |
Most women undergoing uncomplicated laparoscopic hysterectomy can safely go home the same day, according to a new study.
Researchers at Kaiser Permanente Northern California (Oakland, USA) conducted a retrospective case series of 1,015 women discharged home after total or supracervical laparoscopic hysterectomy in a managed care setting, over a three period. Chart reviews were performed for outcomes of interest, which included readmission rates, emergency visits, and surgical and demographic characteristics. The two hysterectomy groups were compared using χ2 tests for categorical variables and t-tests or Wilcoxon rank-sum tests for continuously measured variables.
The results showed that 527 patients (52%) were discharged home the same-day; of those, 46% had total laparoscopic hysterectomies and 54% had supracervical hysterectomies. Cumulative readmission rates were 0.6%, 3.6%, and 4.0% at 48 hours, 3 months, and 12 months, respectively. The most common readmission diagnoses included abdominal incision infection, cuff dehiscence, and vaginal bleeding. Less than 4% of patients presented for emergency care within 48 or 72 hours, most commonly for nausea or vomiting, pain, and urinary retention. There was no difference in readmission rates or emergency visits for the total compared with the supracervical laparoscopic hysterectomy group. The study was published in the May 2011 issue of Obstetrics & Gynecology.
"There was a time when it was considered unusual to send an uncomplicated laparoscopic cholecystectomy home the same day, and now it is standard practice," said lead author Eve Zaritsky, MD. "This study provides evidence that women do not necessarily need to stay in the hospital and thus can enjoy the quiet and comfort of their own home."
Hysterectomy, the surgical removal of the uterus, may be total, involving the removal of the body, fundus, and cervix of the uterus, or supracervical, involving the removal of the uterine body while leaving the cervix intact. It is the most commonly performed gynecological surgical procedure, with over 600,000 hysterectomies performed annually in the United States alone, 90% of which were performed for benign conditions. Such rates, the highest in the industrialized world, has led to a major controversy claiming that hysterectomies are being largely performed for unwarranted and unnecessary reasons.
Related Links:
Kaiser Permanente Northern California
Researchers at Kaiser Permanente Northern California (Oakland, USA) conducted a retrospective case series of 1,015 women discharged home after total or supracervical laparoscopic hysterectomy in a managed care setting, over a three period. Chart reviews were performed for outcomes of interest, which included readmission rates, emergency visits, and surgical and demographic characteristics. The two hysterectomy groups were compared using χ2 tests for categorical variables and t-tests or Wilcoxon rank-sum tests for continuously measured variables.
The results showed that 527 patients (52%) were discharged home the same-day; of those, 46% had total laparoscopic hysterectomies and 54% had supracervical hysterectomies. Cumulative readmission rates were 0.6%, 3.6%, and 4.0% at 48 hours, 3 months, and 12 months, respectively. The most common readmission diagnoses included abdominal incision infection, cuff dehiscence, and vaginal bleeding. Less than 4% of patients presented for emergency care within 48 or 72 hours, most commonly for nausea or vomiting, pain, and urinary retention. There was no difference in readmission rates or emergency visits for the total compared with the supracervical laparoscopic hysterectomy group. The study was published in the May 2011 issue of Obstetrics & Gynecology.
"There was a time when it was considered unusual to send an uncomplicated laparoscopic cholecystectomy home the same day, and now it is standard practice," said lead author Eve Zaritsky, MD. "This study provides evidence that women do not necessarily need to stay in the hospital and thus can enjoy the quiet and comfort of their own home."
Hysterectomy, the surgical removal of the uterus, may be total, involving the removal of the body, fundus, and cervix of the uterus, or supracervical, involving the removal of the uterine body while leaving the cervix intact. It is the most commonly performed gynecological surgical procedure, with over 600,000 hysterectomies performed annually in the United States alone, 90% of which were performed for benign conditions. Such rates, the highest in the industrialized world, has led to a major controversy claiming that hysterectomies are being largely performed for unwarranted and unnecessary reasons.
Related Links:
Kaiser Permanente Northern California
Latest Patient Care News
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
Channels
Critical Care
view channel
Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
For individuals with Type 1 diabetes, hypoglycemia (low blood sugar) presents a life-threatening threat, particularly when glucose levels drop too low, which can result in seizures, coma, or even death.... Read more
New Prostate Screening Device Could Replace Traditional Examination Method
Prostate cancer is a leading health concern, with one in seven men being diagnosed with the disease. Early detection is critical for improving patient outcomes, but traditional diagnostic methods, such... Read moreSurgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more